Visgo Therapeutics Overview
- Founded
-
2013

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Visgo Therapeutics General Information
Description
Developer of medical therapies designed to treat joint disease such as osteoarthritis (OA). The company's medical therapies are microparticle that can be loaded with drugs and delivered by intra-articular (IA) injection for release over time within the joint, with minimal systemic exposure, enabling patients to get relief from joint pain and osteoarthritis.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Delivery
Primary Office
- 67 South Bedford Street
- Suite 400W
- Burlington, MA 01803
- United States
Visgo Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Jul-2017 | 00000 | Completed | Out of Business | ||
1. Angel (individual) | 05-Mar-2015 | 00000 | 00000 | Completed | Startup |
Visgo Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of medical therapies designed to treat joint disease such as osteoarthritis (OA). The company's medical therap
Pharmaceuticals
Burlington, MA
00000
00000000 00
00000
Visgo Therapeutics Competitors (12)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Xalud Therapeutics | Venture Capital-Backed | New York, NY | 00 | 0000 | 00000000000 | 0000 |
000000 0000000 | Venture Capital-Backed | Milpitas, CA | 00 | 00000 | 00000000000 | 00000 |
0000000000 0000000 | Formerly VC-backed | Stockholm, Sweden | 00 | 00000 | 000000000 | 00000 |
0000000 0000000000 | Venture Capital-Backed | San Diego, CA | 00 | 00000 | 00000000000 | 00000 |
0000000 | Formerly VC-backed | Boston, MA | 0000 | 000000&0 |
Visgo Therapeutics Patents
Visgo Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2016209477-A1 | Injectable aggregates for joint and soft tissue distress | Abandoned | 20-Jan-2015 | 000000000 | |
JP-2018502897-A | Injectable aggregates for joint and soft tissue pain | Pending | 20-Jan-2015 | 000000000 | |
US-20180000737-A1 | Injectable aggregates for joint and soft tissue distress | Abandoned | 20-Jan-2015 | 000000000 | 0 |
EP-3247462-A4 | Injectable aggregates for joint and soft tissue distress | Withdrawn | 20-Jan-2015 | 000000000 | 0 |
EP-3247462-A1 | Injectable aggregates for joint and soft tissue distress | Withdrawn | 20-Jan-2015 | A61K9/146 |
Visgo Therapeutics Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Peter Rock | Chief Financial Officer | ||
Pamela Hay JD | Co-Founder, President & Chairman |
Visgo Therapeutics Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Pamela Hay JD | Self | Co-Founder, President & Chairman | 000 0000 |